Skip to main content

This page is intended for UK healthcare professionals and other relevant decision makers only. If you are a member of the public, please click here.

This portal is funded and owned by Novartis Pharmaceuticals UK Ltd and includes content approved by Novartis.

Adverse events reporting information can be found in the footer of this page.

Novartis Pro UK

Main navigation

    Menu
  • Medicines
    • Cardio-metabolic
      • LEQVIO®▼ (inclisiran)
    • Dermatology
      • COSENTYX® (secukinumab)
    • Haematology
      • FABHALTA®▼ (iptacopan)
      • SCEMBLIX®▼ (asciminib)
    • Immunology
    • Neuroscience
      • AIMOVIG® (erenumab)
      • KESIMPTA®▼ (ofatumumab)
    • Oncology
      • KISQALI® (ribociclib)
      • TAFINLAR® (dabrafenib) + MEKINIST® (trametinib) in melanoma
      • SANDOSTATIN® LAR® (octreotide acetate)
    • Respiratory and Inflammation
    • Rheumatology
      • COSENTYX® (secukinumab)
  • Therapy Areas
    • Cardio-metabolic
    • Dermatology
    • Haematology
    • Immunology
    • Neuroscience
    • Oncology
    • Respiratory and inflammation
    • Rheumatology
  • Events
  • Resources
  • Healthcare Systems Support
    • Disease area service resources
      • Service resources: Oncology
      • Breast Cancer Inequalities Tool
    • Collaborative Working
    • Contact us
Login
What are you looking for?
top
439 results found
Preview image. Xolair patient self-administration online starter-kit: A guide to self-injection PDF.

document - 25 Sep 2024
Facebook X Linkedin
Self-administration starter kit (2): A guide to self injection
Preview image. Xolair patient self-administration online starter-kit: Things to fill in PDF.

document - 25 Sep 2024
Facebook X Linkedin
Self-administration starter kit (3): Things for you to fill in
Preview image. Xolair patient self-administration online starter-kit: Important information PDF.

document - 25 Sep 2024
Facebook X Linkedin
Self-administration starter kit (4): Important information
Preview image: Xolair patient self-administration online starter kit: a guide to self-injection PDF.

document - 28 Aug 2024
Facebook X Linkedin
Self-administration starter kit (2): A guide to self injection
Preview image: Your daily tracker PDF.

document - 29 Oct 2024
Facebook X Linkedin
Your daily tracker
Preview image: Xolair patient self-administration online starter kit: things for you to fill in PDF.

document - 28 Aug 2024
Facebook X Linkedin
Self-administration starter kit (3): Things for you to fill in
Preview image: Your weekly tracker PDF.

document - 29 Oct 2024
Facebook X Linkedin
Your weekly tracker
Preview image: Your monthly tracker PDF.

document - 29 Oct 2024
Facebook X Linkedin
Your monthly tracker
Preview image: Xolair patient self-administration online starter kit: important information PDF.

document - 28 Aug 2024
Facebook X Linkedin
Self-administration starter kit (4): Important information
Preview image: instruction video for Xolair injection.

video - 01 Oct 2024
6 mins 29 secs
Facebook X Linkedin
Instruction video for self-injection (pre-filled syringe)
This video provides a comprehensive guide on how to safely self-administer Xolair injections at home. It covers step-by-step instructions, safety precautions, and important tips for handling the prefilled syringe.
(439)
  • See more results
    179 remaining items

Novartis Pharmaceuticals UK Limited is a limited liability company registered in England and Wales under number 119006.


Registered office: The WestWorks Building, White City Place, 195 Wood Lane, London, W12 7FQ.

UK | March 2025 | FA-11207513-2
 

Explore the Site
  • Medicines
  • Therapy areas
  • Events
  • Resources
  • Healthcare Systems Support
Helpful Links
  • Privacy Notice
  • Terms of Use
  • Accessibility
  • Contact us

© 2025 Novartis Pharmaceuticals UK Limited. All rights reserved.

people chatting in the office

Welcome to Pro.Novartis.com

The Novartis portal for UK healthcare professionals (HCPs) and other relevant decision makers* is where you can find promotional information about Novartis products, therapy area materials and professional resources.

*Other relevant decision makers particularly includes those with an NHS role who could influence in any way the administration, consumption, prescription, purchase, recommendation, sale, supply or use of any medicine but who are not health professionals.

I am a UK healthcare professional and/or an NHS professional involved in service or budgetary planning responsibilities
I am a member of the public
people chatting in the office

Welcome to Pro.Novartis.com

The Novartis portal for UK healthcare professionals (HCPs) and other relevant decision makers* is where you can find promotional information about Novartis products, therapy area materials and professional resources.

*Other relevant decision makers particularly includes those with an NHS role who could influence in any way the administration, consumption, prescription, purchase, recommendation, sale, supply or use of any medicine but who are not health professionals.

I am a UK healthcare professional and/or an NHS professional involved in service or budgetary planning responsibilities
I am a member of the public